Subject: Point-of-Care COVID and THC Diagnostic Test
Steve McMaster Member: 2020 Posts:
Submitted on 10-12-20 12:55 pm Message:
Good morning everyone,
I am seeking advice for a startup that I'm advising. The company has developed a saliva testing device with a 5-minute turnaround for COVID detection, with greater than 90% accuracy. This device also detects real-time THC levels in a patient's blood. It's an incredible piece of technology, and its multi-use functionality holds true to its original thesis.
The company has several LOI's for large purchase volumes, and is soon concluding its clinical trials.
What is the typical multiple, or other preferred methods, for valuing a pre-revenue company in the medical device space?